ATCC - Development of Assays for Influenza (NEW CONTRACT IN FY24)
Past New Requirement Updated
- Agency
-
Centers for Disease Control and Prevention
Department of Health and Human Services
- Solicitation expected
- Not on record
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- Not on record
- Points of contact
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) is forecasting a new contract for the development of influenza assays, scheduled for award on October 1, 2024. The contract appears to focus on creating specialized diagnostic or research assays related to influenza, with ATCC (American Type Culture Collection) potentially being the incumbent contractor. This opportunity represents a new requirement for the fiscal year 2024, indicating a potential innovative approach to influenza research and diagnostic capabilities.
While specific award value details are not provided in the forecast, the contract will involve the CDC and is directly managed by Vic Veguilla, who can be contacted at dhu3@cdc.gov. The contract does not have a specific set-aside designation, suggesting it is open to competitive bidding from qualified contractors. The opportunity is posted with a forecast date of December 10, 2025, which suggests potential long-term planning and strategic development of influenza-related research and diagnostic tools.
Forecast text
ATCC - Development of Assays for Influenza (NEW CONTRACT IN FY24)
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast